Brief Description
CellASIC¨ ONIX Microfluidic Platform delivers precise control for live cell analysis experiments by facilitating long-term perfusion cell culture. Cutting-edge microfluidics technology provides an improved cell culture microenvironment, exceptional quality for high magnification microscopy, and superior media switching capabilities.
The company was founded by UC Berkeley Professor of Bioengineering Luke Lee and his graduate students Paul Hung and Philip Lee.
Timeline
- 2004. Company founded
- 2012. CellASIC Corp. was acquired by Merck and merged with EMD Millipore Corp.
Inventors
Ju Sung Hung, Luke Lee, Philip Lee